Arcturus Therapeutics stock rockets higher amid expansion of Ultragenyx collaboration
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) shares surged after the messenger RNA medicine company announced Wednesday the continuation of its collaboration with Ultragenyx Pharmaceutical Inc (NASDAQ:RARE).
The companies plan to discover and develop mRNA, DNA and small interfering RNA therapeutics to target a slate of rare diseases.
Arcturus shares jumped 43% to $8.31. Shares of Ultragenyx, a large-cap pharmaceutical company, ticked up 0.1% to $62.36.
READ: Melinta stock doubles on FDA approval of a supplemental new drug application for BAXDELA to treat pneumonia
The partnership will pay Arcturus for major milestones reached in the development process. The two companies have been working together since October 2015.
The first such treatment is designed to treat Glycogen Storage Disease Type III, a hereditary disorder that impairs the body’s ability to break down carbohydrates.
“The expansion of the collaboration with Ultragenyx underscores the partnership’s early successes and ongoing commitment,” CEO Joseph Payne said. “Our expertise in the discovery, early development and manufacturing of RNA medicines aligns well with Ultragenyx’s proven clinical development and commercial experience in rare diseases.”
Arcturus Therapeutics is an RNA medicines company based in San Diego, California. Itstreatment pipeline includes therapies for Ornithine Transcarbamylase Deficiency, Cystic Fibrosis, Glycogen Storage Disease Type 3, Hepatitis B, and non-alcoholic steatohepatitis.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/222433/arcturus-therapeutics-stock-rockets-higher-amid-expansion-of-ultragenyx-collaboration-222433.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes:
Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.
| Online: | |
| Visits: | 1,608,832,471 |
| Stories: | 8,165,870 |
Whistler Blowers, Insiders
